Literature DB >> 15220510

Arterial MR imaging phase-contrast flow measurement: improvements with varying velocity sensitivity during cardiac cycle.

Steffen Ringgaard1, Sten A Oyre, Erik M Pedersen.   

Abstract

To reduce noise in velocity images of magnetic resonance (MR) phase-contrast measurements, the authors implemented and evaluated a pulse sequence that enables automatic optimization of the velocity-encoding parameter V(enc) for individual heart phases in pulsatile flow on the basis of a rapid prescan. This sequence was prospectively evaluated by comparing velocity-to-noise ratios with those from a standard MR flow scan obtained in the carotid artery in eight volunteers. This sequence was shown to improve velocity-to-noise ratios by a factor of 2.0-6.0 in all but the systolic heart phase and was determined to be an effective technique for reducing noise in phase-contrast velocity measurements. Copyright RSNA, 2004

Mesh:

Year:  2004        PMID: 15220510     DOI: 10.1148/radiol.2321030783

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  Efficient triple-VENC phase-contrast MRI for improved velocity dynamic range.

Authors:  Liliana E Ma; Michael Markl; Kelvin Chow; Alireza Vali; Can Wu; Susanne Schnell
Journal:  Magn Reson Med       Date:  2019-08-18       Impact factor: 4.668

2.  Three-dimensional, isotropic MRI: a unified approach to quantification and visualization in congenital heart disease.

Authors:  Thomas Sangild Sørensen; Philipp Beerbaum; Hermann Körperich; Erik Morre Pedersen
Journal:  Int J Cardiovasc Imaging       Date:  2005 Apr-Jun       Impact factor: 2.357

Review 3.  Advanced techniques for MRI of atherosclerotic plaque.

Authors:  William S Kerwin; Gador Canton
Journal:  Top Magn Reson Imaging       Date:  2009-08

4.  Real-time phase-contrast flow cardiovascular magnetic resonance with low-rank modeling and parallel imaging.

Authors:  Aiqi Sun; Bo Zhao; Yunduo Li; Qiong He; Rui Li; Chun Yuan
Journal:  J Cardiovasc Magn Reson       Date:  2017-02-10       Impact factor: 5.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.